Literature DB >> 8692692

MoMuLV proviral integrations identified by Sup-F selection in tumors from infected myc/pim bitransgenic mice correlate with activation of the gfi-1 gene.

T Schmidt1, M Zörnig, R Beneke, T Möröy.   

Abstract

Infecting mice with a mutant Moloney murine leukemia virus which contains the bacterial suppressor tRNA supF in its LTR allows rapid cloning of proviral integration sites from genomic tumour DNA. In a previous study Emu pim-1/Emu L-myc bitransgenic mice had been inoculated neonatally with MoMuLV supF virus. The retroviral infection led to acceleration of lymphomagenesis indicating the proviral activation of further oncogenes cooperating with myc and pim-1 in tumour development. Using a functional supF screen for analysis of genomic mouse tumour DNA libraries which had been constructed in the phage vector EMBL3A, a common proviral integration site on mouse chromosome 5 was cloned and found to be identical to the proviral integration site evi-5 which has recently been identified in an AKXD T-cell lymphoma and which is located 18 kb upstream of the gfi-1 gene. Tumours bearing evi-5 integrations showed an enhanced gfi-1 expression level suggesting that gfi-1 is the target gene for insertions at the evi-5 locus. Together with three other previously described Moloney integration clusters all responsible for enhanced gfi-1 expression the number of tumours from infected double transgenic Emu L-myc/Emu pim-1 transgenic mice with retrovirally activated gfi-1 added up to 53% underscoring the role of GFI-1 as an effective collaborator for MYC and PIM-1 in the process of lymphomagenesis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8692692      PMCID: PMC145976          DOI: 10.1093/nar/24.13.2528

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  27 in total

Review 1.  Tumorigenesis by slow-transforming retroviruses--an update.

Authors:  M van Lohuizen; A Berns
Journal:  Biochim Biophys Acta       Date:  1990-12-11

Review 2.  Transgenic models for haemopoietic malignancies.

Authors:  J M Adams; S Cory
Journal:  Biochim Biophys Acta       Date:  1991-04-16

3.  Long-distance activation of the Myc protooncogene by provirus insertion in Mlvi-1 or Mlvi-4 in rat T-cell lymphomas.

Authors:  P A Lazo; J S Lee; P N Tsichlis
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

4.  The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice.

Authors:  J M Adams; A W Harris; C A Pinkert; L M Corcoran; W S Alexander; S Cory; R D Palmiter; R L Brinster
Journal:  Nature       Date:  1985 Dec 12-18       Impact factor: 49.962

5.  Replication-competent Moloney murine leukemia virus carrying a bacterial suppressor tRNA gene: selective cloning of proviral and flanking host sequences.

Authors:  W Reik; H Weiher; R Jaenisch
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

Review 6.  Transgenic mice as probes into complex systems.

Authors:  D Hanahan
Journal:  Science       Date:  1989-12-08       Impact factor: 47.728

7.  Mice bearing the E mu-myc and E mu-pim-1 transgenes develop pre-B-cell leukemia prenatally.

Authors:  S Verbeek; M van Lohuizen; M van der Valk; J Domen; G Kraal; A Berns
Journal:  Mol Cell Biol       Date:  1991-02       Impact factor: 4.272

8.  IgH enhancer deregulated expression of L-myc: abnormal T lymphocyte development and T cell lymphomagenesis.

Authors:  T Möröy; P Fisher; C Guidos; A Ma; K Zimmerman; A Tesfaye; R DePinho; I Weissman; F W Alt
Journal:  EMBO J       Date:  1990-11       Impact factor: 11.598

9.  Driven by the same Ig enhancer and SV40 T promoter ras induced lung adenomatous tumors, myc induced pre-B cell lymphomas and SV40 large T gene a variety of tumors in transgenic mice.

Authors:  Y Suda; S Aizawa; S Hirai; T Inoue; Y Furuta; M Suzuki; S Hirohashi; Y Ikawa
Journal:  EMBO J       Date:  1987-12-20       Impact factor: 11.598

10.  The E mu-myc transgenic mouse. A model for high-incidence spontaneous lymphoma and leukemia of early B cells.

Authors:  A W Harris; C A Pinkert; M Crawford; W Y Langdon; R L Brinster; J M Adams
Journal:  J Exp Med       Date:  1988-02-01       Impact factor: 14.307

View more
  27 in total

1.  The zinc-finger proto-oncogene Gfi-1b is essential for development of the erythroid and megakaryocytic lineages.

Authors:  Shireen Saleque; Scott Cameron; Stuart H Orkin
Journal:  Genes Dev       Date:  2002-02-01       Impact factor: 11.361

2.  Transcription factor Gfi1 regulates self-renewal and engraftment of hematopoietic stem cells.

Authors:  Hui Zeng; Raif Yücel; Christian Kosan; Ludger Klein-Hitpass; Tarik Möröy
Journal:  EMBO J       Date:  2004-09-23       Impact factor: 11.598

Review 3.  Gfi/Pag-3/senseless zinc finger proteins: a unifying theme?

Authors:  Hamed Jafar-Nejad; Hugo J Bellen
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

4.  A genetic screen in Drosophila for genes interacting with senseless during neuronal development identifies the importin moleskin.

Authors:  Kathryn L Pepple; Aimée E Anderson; Benjamin J Frankfort; Graeme Mardon
Journal:  Genetics       Date:  2006-11-16       Impact factor: 4.562

5.  Gfi1 functions downstream of Math1 to control intestinal secretory cell subtype allocation and differentiation.

Authors:  Noah F Shroyer; Deeann Wallis; Koen J T Venken; Hugo J Bellen; Huda Y Zoghbi
Journal:  Genes Dev       Date:  2005-10-15       Impact factor: 11.361

6.  Gfi1b alters histone methylation at target gene promoters and sites of gamma-satellite containing heterochromatin.

Authors:  Lothar Vassen; Katharina Fiolka; Tarik Möröy
Journal:  EMBO J       Date:  2006-05-11       Impact factor: 11.598

7.  Growth factor independent 1b (Gfi1b) and a new splice variant of Gfi1b are highly expressed in patients with acute and chronic leukemia.

Authors:  Lothar Vassen; Cyrus Khandanpour; Peter Ebeling; Bert A van der Reijden; Joop H Jansen; Stefan Mahlmann; Ulrich Dührsen; Tarik Möröy
Journal:  Int J Hematol       Date:  2009-04-10       Impact factor: 2.490

8.  The Gfi-1B proto-oncoprotein represses p21WAF1 and inhibits myeloid cell differentiation.

Authors:  B Tong; H L Grimes; T Y Yang; S E Bear; Z Qin; K Du; W S El-Deiry; P N Tsichlis
Journal:  Mol Cell Biol       Date:  1998-05       Impact factor: 4.272

9.  Loss of GFI1 impairs pulmonary neuroendorine cell proliferation, but the neuroendocrine phenotype has limited impact on post-naphthalene airway repair.

Authors:  R Ilona Linnoila; Sandra Jensen-Taubman; Avedis Kazanjian; H Leighton Grimes
Journal:  Lab Invest       Date:  2007-04       Impact factor: 5.662

10.  Targets of the transcriptional repressor oncoprotein Gfi-1.

Authors:  Zhijun Duan; Marshall Horwitz
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-29       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.